BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 3581480)

  • 21. Order of events leading to surface immunoglobulin capping: analysis of a transmembrane signal.
    Young-Karlan BR; Ashman RF
    J Immunol; 1981 Sep; 127(3):1177-81. PubMed ID: 6790615
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lymphocyte capping: a diagnostic method in progressive muscular dystrophy?
    Nordal HJ; Andersson TR; Dietrichson P
    Acta Neurol Scand; 1982 May; 65(5):442-7. PubMed ID: 7113656
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Possibility of prenatal diagnosis of progressive muscular dystrophy: evaluation of creatine kinase activity in serum and the capping of lymphocytes].
    Venturoli A; Sensi A; Baricordi R; Artioli A; Osti L; Mari R; Ferroni G; Lucci M
    Boll Soc Ital Biol Sper; 1983 Dec; 59(12):1988-94. PubMed ID: 6608363
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lymphocyte capping in carriers of Duchenne muscular dystrophy.
    Bader PI
    N Engl J Med; 1979 Sep; 301(13):725. PubMed ID: 481472
    [No Abstract]   [Full Text] [Related]  

  • 25. Lymphocyte capping and carrier detection in Duchenne muscular dystrophy.
    Sybert VP
    Lancet; 1979 Sep; 2(8144):698. PubMed ID: 90791
    [No Abstract]   [Full Text] [Related]  

  • 26. Lymphocyte capping in carriers of Duchenne muscular dystrophy.
    Sybert VP; Setran KN; Kadin ME
    N Engl J Med; 1979 Sep; 301(13):724-5. PubMed ID: 481471
    [No Abstract]   [Full Text] [Related]  

  • 27. Lymphocyte capping in myotonic dystrophy.
    Walker GL; Karagol U; Mathieson EC; Lane RJ; Mastaglia FL
    J Neurol Neurosurg Psychiatry; 1983 Jan; 46(1):90-2. PubMed ID: 6601689
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Model for capping derived from inhibition of surface receptor capping by free fatty acids.
    Klausner RD; Bhalla DK; Dragsten P; Hoover RL; Karnovsky MJ
    Proc Natl Acad Sci U S A; 1980 Jan; 77(1):437-41. PubMed ID: 6928636
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of antigen-induced and anti-immunoglobulin-induced capping by hydrocortisone and propranolol.
    Ashman RF; Karlan BR
    Immunopharmacology; 1981 Feb; 3(1):41-7. PubMed ID: 6971857
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lymphocyte capping in Duchenne muscular dystrophy.
    N Engl J Med; 1979 Apr; 300(15):861-2. PubMed ID: 311414
    [No Abstract]   [Full Text] [Related]  

  • 31. Failure to demonstrate abnormal lymphocyte capping in humans, mice and hamsters with muscular dystrophy.
    Gershwin ME; Taylor RG; Fowler WM; Finlayson B
    Hum Genet; 1979; 53(1):113-4. PubMed ID: 317066
    [No Abstract]   [Full Text] [Related]  

  • 32. Two distinct mechanisms for redistribution of lymphocyte surface macromolecules. II. Contrasting effects of local anesthetics and a calcium ionophore.
    Braun J; Fujiwara K; Pollard TD; Unanue ER
    J Cell Biol; 1978 Nov; 79(2 Pt 1):419-26. PubMed ID: 363728
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Membrane fluidity of nonmuscle cells in Duchenne muscular dystrophy: effect on lymphocyte membranes of incubation in patient and control sera.
    Hübner C; Kohlschütter A; Gärtner J
    Pediatr Res; 1987 Oct; 22(4):488-92. PubMed ID: 3684376
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of lymphocyte capping and transformation by propranolol and related compounds.
    Anderton BH; Axford JS; Cohn P; Marshall NJ; Shen L; Sprake S
    Br J Pharmacol; 1981 Jan; 72(1):69-74. PubMed ID: 6112036
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lymphocyte capping in hereditary muscular dystrophic chickens and mice: no evidence for a systemic membrane defect.
    Sanders BG; Kline K; Morton CJ
    J Hered; 1980; 71(2):100-4. PubMed ID: 7391533
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A membrane fluidizing factor in sera from Duchenne muscular dystrophy patients: effect on lymphocyte membranes of incubation in patient and control lipoproteins.
    Hübner C; Wiehler U; Lindner SG; Beisiegel U; Claussen M; Albani M; Kohlschütter A
    Pediatr Res; 1989 Jun; 25(6):656-9. PubMed ID: 2740157
    [TBL] [Abstract][Full Text] [Related]  

  • 37. E rosette dissociation: evidence for a role of the cytoskeleton.
    Brohee D; Kennes B; Neve P
    Clin Exp Immunol; 1982 Aug; 49(2):474-80. PubMed ID: 7127913
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cap formation by various ligands on lymphocytes shows the same dependence on high cellular ATP levels.
    Pozzan T; Corps AN; Montecucco C; Hesketh TR; Metcalfe JC
    Biochim Biophys Acta; 1980 Nov; 602(3):558-66. PubMed ID: 6776985
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Duchenne muscular dystrophy: alterations in lymphocyte fluidity.
    Ferretti G; Falcioni AM; Curatola G; Valentini B; Saccucci F
    Boll Soc Ital Biol Sper; 1983 Jul; 59(7):1035-40. PubMed ID: 6626329
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antibody-induced redistribution and shedding of membrane proteins in Duchenne muscular dystrophy lymphocytes.
    Migone N; Belvedere M; Richiardi P; Carbonara AO; Bergamini L
    Ital J Neurol Sci; 1980 Jun; 1(3):177-9. PubMed ID: 7341543
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.